Paul Hastings is the founder of Nkarta Therapeutics. Nkarta Therapeutics has raised $404M in total funding. Latest round: IPO.
Paul Hastings is the Chief Executive Officer and President of Nkarta Therapeutics, a clinical-stage biopharmaceutical company. He was appointed CEO in March 2018 to lead the company's next phase of growth, overseeing multiple funding rounds including a $289.8M IPO.
Full founder directory · Investor directory · Company funding database · Fundraising library